Palilalia
Palilalia (from the Greek πάλιν (pálin) meaning "again" and λαλιά (laliá) meaning "speech" or "talk"), is a language disorder characterized by the involuntary repetition of syllables, words, or phrases. It has features in common with other speech disorders such as stuttering and logorrhea, but should not be confused with these conditions.
025==Causes== Palilalia is often associated with Parkinson's disease, Autism, Gilles de la Tourette syndrome, and certain other neurological disorders. It can also occur in the context of schizophrenia, Alzheimer's disease, and stroke. The exact cause of palilalia is not known, but it is thought to involve dysfunction in the brain areas responsible for speech and language.
Symptoms[edit]
The main symptom of palilalia is the involuntary repetition of syllables, words, or phrases. This repetition often occurs rapidly and can be difficult to understand. Other symptoms can include a decrease in the volume of speech over the course of the repetition, and an increase in the speed of speech.
Diagnosis[edit]
Diagnosis of palilalia is typically based on a clinical evaluation, including a detailed history and a thorough neurological examination. Other tests, such as brain imaging studies or neuropsychological testing, may be used to rule out other conditions that can cause similar symptoms.
Treatment[edit]
Treatment for palilalia is typically focused on managing the underlying condition. This can include medication, speech therapy, or other interventions. In some cases, the symptoms of palilalia may improve with treatment of the underlying condition.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
